Hypermethylation Status of E-Cadherin Gene in Gastric Cancer Patients in a High Incidence Area |
Rashid, Haroon
(Department of General and Minimal Invasive Surgery, Sher-I-Kashmir Institute of Medical Sciences)
Alam, Khursheed (Department of General and Minimal Invasive Surgery, Sher-I-Kashmir Institute of Medical Sciences) Afroze, Dil (Department of Immunology and Molecular Medicine, Sher-I-Kashmir Institute of Medical Sciences) Yousuf, Adfar (Department of Immunology and Molecular Medicine, Sher-I-Kashmir Institute of Medical Sciences) Banday, Manzoor (Department of Medical Oncology, Sher-I-Kashmir Institute of Medical Sciences) Kawoosa, Fizalah (Department of Immunology and Molecular Medicine, Sher-I-Kashmir Institute of Medical Sciences) |
1 | Wang K, Yuen ST, Xu J, et al (2014). Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nature Genetics, 46, 573-82. DOI |
2 | Wani M, Afroze D, Makhdoomi M, et al (2012). Promoter Methylation status of DNA repair gene (hMLH1) in gastric carcinoma patients of the Kashmir Valley. Asian Pac J Cancer Prev, 13, 4177-418. DOI |
3 | Yi Kim D, Kyoon Joo J, Kyu Park Y, et al (2007). E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis. J Surg Oncol, 96, 429-35 . DOI |
4 | Yoo TH, Ryu BK, Lee MG, Chi SG (2013). CD81 is a candidate tumor suppressor gene in human gastric cancer. Cell Oncol, 36, 141-53. DOI |
5 | Yousuf A, Bhat MY, Pandith AA, et al (2014). MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area. Cell Oncol, 37, 245-52. DOI |
6 | Zhang KL, Sun Y, Li Y, et al (2008). Increased frequency of CpG island methylator phenotype and CDH1 methylation in a gastric cancer high-risk region of china. Transl Oncol 1, 28-35. DOI |
7 | Zheng Z, Pan J, Chu B, et al (1999). Down¬regulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol, 30, 458-66. DOI |
8 | Zhu AL, Sonnenberg A (2012). Is gastric cancer again rising? J Clin Gastroenterol, 46, 804-6. DOI |
9 | Zouridis H, Deng N, Ivanova T, et al (2012). Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci Transl Med, 4, 156ra140. |
10 | Bussemakers MJ, van Bokhoven A, Mees SG, Kemler R, Schalken JA (1993). Molecular cloning and characterization of the human E-cadherin cDNA. Mol Biol Rep, 17, 123-128. DOI |
11 | Choi IS, Wu TT (2005). Epigenetic alterations in gastric Carcinogenesis. Cell Res, 15, 247-54. DOI |
12 | Correa P (1992). Human gastric carcinogenesis, a multistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res, 52, 6735-40. |
13 | Hu X, Sui X, Li L, et al (2013). Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers. J Pathol, 229, 62-73. DOI |
14 | Du W, Wang S, Zhou Q, et al (2013). ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer. Oncogene, 32, 3319-28. DOI |
15 | Enokida H, Shiina H, Urakami S et al (2005). Ethnic grouprelated differences in CpG hypermethylation of the GSTP1gene promoter among African-American, Caucasian and Asian patientswith prostate cancer. Int J Cancer, 116, 174-81. DOI |
16 | Galanter JM , Christopher RG, Sam SO, et al (2015). Methylation analysis reveals fundamental differences between ethnicity and genetic ancestry. Bio Rxiv. |
17 | Guan Z, Zhang J, Song S, Dai D (2013). Promoter methylation and expression of TIMP3 gene in gastric cancer. Diagn Pathol, 8, 1-6. |
18 | Graziano F, Arduini F, Ruzzo A, et al(2004). Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer. Clin Cancer Res, 10, 2784-9. DOI |
19 | Humar B, Blair V, Charlton A, et al (2009). E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Cancer Res, 69, 2050-6. |
20 | Jemal A, Bray, Center M, Ferlay, Ward E, Forman D (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
21 | Kang GH, Lee HJ, Hwang KS, et al (2003). Aberrant CpG Island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol, 163, 1551-6. DOI |
22 | Parkin DM, Bray F, Ferlay J, Pisani P(2005) . Global cancer statistics 2002. CA Cancer J Clin, 55, 74-108. DOI |
23 | Karayiannakis AJ, Syrigos KN, Chatzigianni E, et al (1998). Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer. Anticancer Res, 18, 4177-80. |
24 | Lee TL, Leung WK, Chan MW et al (2002). Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res, 8, 1761-6. |
25 | Machado JC, Oliveira C, Carvalho R, et al (2001). E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene, 20, 1525-8. DOI |
26 | Oliveira C, Sousa S, Pinheiro H, et al (2009). Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterol, 136, 2137-48. DOI |
27 | Pandith AA, Siddiqi MA (2012). Burden of cancers in the valley of Kashmir, 5 year epidemiological study reveals a different scenario. Tumor Biol, 33, 1629-37. DOI |
28 | Rao V, Ganesh B (1998). Estimate of cancer incidence in India in 1991. Indian J Cancer, 35, 10-18. |
29 | Siegel R, Ma J, Zou Z, Jemal A(2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29. DOI |
30 | Tahara T, Shibata T, Arisawa T, et al (2010). CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer. Anticancer Res, 30, 239-244. |
31 | Takeichi M (1990). Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem, 59, 237-52. DOI |
32 | Van RF (2014). Beyond E-cadherin: roles of other cadherin superfamily members in cancer. Nat Rev Cancer, 14, 121-34. DOI |